<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Transl Clin Pharmacol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Transl Clin Pharmacol</journal-id>
    <journal-id journal-id-type="publisher-id">TCP</journal-id>
    <journal-title-group>
      <journal-title>Translational and Clinical Pharmacology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">2289-0882</issn>
    <issn pub-type="epub">2383-5427</issn>
    <publisher>
      <publisher-name>Korean Society for Clinical Pharmacology and Therapeutics</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7033381</article-id>
    <article-id pub-id-type="doi">10.12793/tcp.2017.25.3.141</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Caffsim: simulation of plasma caffeine concentrations implemented as an R package and Web-applications</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Han</surname>
          <given-names>Sungpil</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cho</surname>
          <given-names>Yong-Soon</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yoon</surname>
          <given-names>Seok-Kyu</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kim</surname>
          <given-names>Hyungsub</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Bae</surname>
          <given-names>Kyun-Seop</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
      </contrib>
    </contrib-group>
    <aff id="A1"><label>1</label>Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul 05505, <country>Republic of Korea</country>.</aff>
    <author-notes>
      <corresp>Correspondence: K. S. Bae; Fax: +82-2-3010-4645, <email>ksbae@amc.seoul.kr</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>9</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>15</day>
      <month>9</month>
      <year>2017</year>
    </pub-date>
    <volume>25</volume>
    <issue>3</issue>
    <fpage>141</fpage>
    <lpage>146</lpage>
    <history>
      <date date-type="received">
        <day>20</day>
        <month>5</month>
        <year>2017</year>
      </date>
      <date date-type="rev-recd">
        <day>01</day>
        <month>9</month>
        <year>2017</year>
      </date>
      <date date-type="accepted">
        <day>05</day>
        <month>9</month>
        <year>2017</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2017 Translational and Clinical Pharmacology</copyright-statement>
      <copyright-year>2017</copyright-year>
      <copyright-holder>Translational and Clinical Pharmacology</copyright-holder>
      <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
        <license-p>It is identical to the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Caffeine is a naturally-occurring central nervous system stimulant found in plant constituents including coffee, cocoa beans, and tea leaves. Consumption of caffeine through imbibing caffeinated drinks is rapidly growing among children, adolescents, and young adults, who tend to be more caffeine-sensitive than the rest of the general public; consequently, caffeine-related toxicities among these groups are also growing in number. However, a quantitative and interactive tool for predicting the plasma caffeine concentration that may lead to caffeine intoxication has yet to be developed. Using the previously established population-pharmacokinetic model, we developed “<italic>caffsim</italic>” R package and its web-based applications using Shiny and EDISON (EDucation-research Integration through Simulation On the Net). The primary aim of the software is to easily predict and calculate plasma caffeine concentration and pharmacokinetic parameters and visualize their changes after single or multiple ingestions of caffeine. The <italic>caffsim</italic> R package helps understand how plasma caffeine concentration changes over time and how long toxic concentration of caffeine can last in caffeine-sensitive groups. It may also help clinical evaluation of relationship between caffeine intake and toxicities when suspicious acute symptoms occur.</p>
    </abstract>
    <kwd-group>
      <kwd>caffeine</kwd>
      <kwd>pharmacokinetics</kwd>
      <kwd>R package</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Research Foundation of Korea</institution>
            <institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003725</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>016M3C1A6936614</award-id>
      </award-group>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Caffeine is a naturally occurring mild central nervous system stimulant that is found in plant constituents such as coffee, cocoa beans, and tea leaves. Caffeine has a long history of human consumption, and is currently used worldwide for enhancing wakefulness, relieving fatigue, and improving mental concentration. Generally, consumption of 400 mg of caffeine per day is safe for healthy adults, which is approximately the amount of caffeine in four cups of brewed coffee, 10 cans of cola, or two caffeinated drinks.[<xref rid="B1" ref-type="bibr">1</xref>] Although typical caffeine use is safe for healthy adults, its effects can be significantly different in caffeine-sensitive groups such as low-weight people including children and adolescents, and the consumption of caffeinated drinks is rapidly growing in these groups.[<xref rid="B2" ref-type="bibr">2</xref>] Consequently, caffeine-related toxicities are growing in number as well[<xref rid="B3" ref-type="bibr">3</xref>]; effects of caffeine intoxication include hallucinations, seizures, metabolic acidosis, rhabdomyolysis, and arrhythmias.[<xref rid="B4" ref-type="bibr">4</xref>] and several reports have associated caffeinated-drink ingestion with serious caffeine intoxication.[<xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref>] In most of cases of emergency room visits related to caffeine intoxication, the patients present with tachyarrhythmia and involves consumption of extremely high doses of caffeine (&gt; 3 mg/kg).[<xref rid="B3" ref-type="bibr">3</xref>] Recently, a series of investigations of high caffeine exposure in adolescents revealed behavioral consequences including sleep-pattern change.[<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>]</p>
    <p>To better explain the relationship between caffeine and its toxicities, a population-pharmacokinetic model was previously established, and Monte Carlo simulations successfully predicted maximal plasma caffeine-concentration profiles after ingestion of a single caffeinated drink.[<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref>] It enables researchers to explore the permissible dose range of caffeine, especially for those who are vulnerable to caffeine overdose. However, a quantitative and interactive tool for predicting and simulating plasma caffeine concentration leading to caffeine intoxication has yet to be developed.</p>
    <p>Using the previously established population-pharmacokinetic model and its parameters.[<xref rid="B11" ref-type="bibr">11</xref>] we developed “<italic>caffsim</italic>” R package and its web-based applications using Shiny and EDISON (EDucation-research Integration through Simulation On the Net, <ext-link ext-link-type="uri" xlink:href="https://www.edison.re.kr/">https://www.edison.re.kr/</ext-link>). The primary aim of the software is allowing for easy prediction of plasma caffeine concentration and visualizing its changes after single or multiple ingestions of caffeine.</p>
  </sec>
  <sec sec-type="methods">
    <title>Methods</title>
    <sec>
      <title>Pharmacokinetic model of caffeine</title>
      <p>A population-pharmacokinetic analysis was previously established based on a study of 30 healthy adult male volunteers of South Asian and European ancestry.[<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>] and Lee et al.[<xref rid="B11" ref-type="bibr">11</xref>] further investigated the model using Monte Carlo simulations to predict C<sub>max</sub> and AUC of caffeine in children.One-compartment model with first-order absorption kinetics and first-order elimination kinetics was shown to be well-fitted to the pharmacokinetic data, and the final pharmacokinetic parameters were adopted from the previous study[<xref rid="B11" ref-type="bibr">11</xref>] for development of the package.</p>
    </sec>
    <sec>
      <title><italic>Caffsim</italic> R package</title>
      <p><italic>Caffsim</italic> was developed in the open-source R programming language in order to allow contribution from anyone interested in the study (<ext-link ext-link-type="uri" xlink:href="https://github.com/asancpt/caffsim">https://github.com/asancpt/caffsim</ext-link>). It is freely available for download on the CRAN repository (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=caffsim">https://CRAN.R-project.org/package=caffsim</ext-link>), and the installation can be carried out by typing <inline-formula><inline-graphic xlink:href="tcp-25-141-i002.jpg"/></inline-formula> in the R console. The package utilizes data manipulation or visualization packages such as dplyr, tidyr, ggplot2[<xref rid="B12" ref-type="bibr">12</xref>] and Shiny. Contents of the <italic>caffsim</italic> R package can be broadly categorized into three main functions—single dosing simulations, multiple dosing simulations, and the other functions including descriptive statistics of pharmacokinetic parameters and a duration of toxic concentration, and execution of Shiny application (<xref rid="T1" ref-type="table">Table 1</xref>). Detailed documentation and examples for each function can be found on the online user manual on the CRAN repository, a package website (<ext-link ext-link-type="uri" xlink:href="https://asancpt.github.io/caffsim">https://asancpt.github.io/caffsim</ext-link>) or directly within the R console by entering ?function (<inline-formula><inline-graphic xlink:href="tcp-25-141-i003.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="tcp-25-141-i004.jpg"/></inline-formula>) after the installation.</p>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <sec>
      <title>Usage of <italic>caffsim</italic> R package</title>
      <p>Workflow of the <italic>caffsim</italic> R package and examples of its main functions are shown in <xref ref-type="fig" rid="F1">Fig. 1</xref> and <xref ref-type="fig" rid="F2">2</xref> The process starts with generation of the concentration-time data by <inline-formula><inline-graphic xlink:href="tcp-25-141-i005.jpg"/></inline-formula> for single dosing simulations and <inline-formula><inline-graphic xlink:href="tcp-25-141-i006.jpg"/></inline-formula> for multiple dosing simulations (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). The generated data frame can be then used as an input argument of <inline-formula><inline-graphic xlink:href="tcp-25-141-i007.jpg"/></inline-formula> function or <inline-formula><inline-graphic xlink:href="tcp-25-141-i008.jpg"/></inline-formula> function, which generates concentration-time plots (<xref ref-type="fig" rid="F2">Fig. 2B</xref>) The properties (log-y scale, line colors, shape of points, etc.) of the plots can be further manipulated or overwritten by adding ‘+’ pipe and functions of ggplot2. The data generated by functions <inline-formula><inline-graphic xlink:href="tcp-25-141-i005.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="tcp-25-141-i006.jpg"/></inline-formula> can be passed to <inline-formula><inline-graphic xlink:href="tcp-25-141-i009.jpg"/></inline-formula>, which calculates the duration of concentration over certain levels that may lead to fatal toxicities, while showing the proportion (%) of population which exceeds such levels (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="supplementary-material" rid="S1">Supplementary Table 1</xref>).</p>
    </sec>
    <sec>
      <title>Application of <italic>caffsim</italic> R package to investigate pharmacokinetics of multiple oral dosing</title>
      <p>The concentration-time profiles of caffeine following 5-times multiple oral doses of 100, 250, 400, and 550 mg (n = 200 each) in combination with dosing intervals 8 hr, 4 hr, 2 hr, and 1 hr with respect to body weights are shown in <xref ref-type="fig" rid="F3">Fig. 3</xref> The known covariate, body weights.[<xref rid="B11" ref-type="bibr">11</xref>] were shown to affect the clearance of caffeine, volume of distribution and k<sub>a</sub> (absorption rate constant); low-weighted population was found to have significantly high AUC, but subjects with body weights &gt; 70 kg generally maintained low C<sub>av,ss</sub> (average concentration at steady-state) levels (&lt; 10 mg/L). We also observed that multiple larger doses of caffeine (&gt; 400 mg) increased its steady-state concentration, which was generally maintained above 10 mg/L, a level considered safe for the multiple dosing of less than 250 mg.</p>
    </sec>
    <sec>
      <title>Application of <italic>caffsim</italic> R package for developing web-based applications</title>
      <p>The <italic>Caffeine Concentration Predictor</italic> Shiny web-application is freely available online (<ext-link ext-link-type="uri" xlink:href="https://asan.shinyapps.io/caff">https://asan.shinyapps.io/caff</ext-link>) for a responsive simulation of the data; it can also be obtained by typing <inline-formula><inline-graphic xlink:href="tcp-25-141-i010.jpg"/></inline-formula>in the R console as shown in <xref ref-type="fig" rid="F4">Fig. 4</xref> The web-application is fully supported in mobile web-browsers (<xref ref-type="fig" rid="F4">Fig. 4D</xref>) as well as desktop web-browsers (<xref ref-type="fig" rid="F4">Fig. 4A-C</xref>). The source R script of the Shiny web-application is open to the public (<ext-link ext-link-type="uri" xlink:href="https://github.com/asancpt/shiny-caff">https://github.com/asancpt/shiny-caff</ext-link>). For education purposes, the EDISON Science App, CaffeineEdison (<ext-link ext-link-type="uri" xlink:href="https://www.edison.re.kr/web/cmed/run_simulation">https://www.edison.re.kr/web/cmed/run_simulation</ext-link>) was generated based on the <italic>caffsim</italic> R package. Although EDISON Science App does not support responsive web designs and mobile web browsers, registered students can easily perform a simulation in desktop computers, and each simulation can be recorded and reviewed later (<xref ref-type="fig" rid="F5">Fig. 5</xref>). The source R script of the EDISON Science App is also open to the public (<ext-link ext-link-type="uri" xlink:href="https://github.com/asancpt/edison-caff">https://github.com/asancpt/edison-caff</ext-link>).</p>
    </sec>
  </sec>
  <sec sec-type="discussion">
    <title>Discussion</title>
    <p>We developed an R package: <italic>caffsim</italic> as a comprehensive tool for simulating plasma caffeine concentration. It is mainly targeted for researchers who study caffeine or other stimulants, and particularly those who have only basic knowledge of R, visualization, or web-based applications. We aimed to implement the following functionalities to perform a simulation: 1) An easy and straightforward generation of concentration-time data; 2) visualization of changes of concentration in single and multiple dosing; 3) a cross-platform software that can be operated in both desktop and mobile web browsers as well as in the R console; 4) an open-source software on which discussion and suggestions from users can be freely exchanged. Based on our results, we believe that the <italic>caffsim</italic> R package meets the objectives described above.</p>
    <p>Predicting the exact plasma caffeine concentration at a given time is critical for assessing the effect of caffeine exposure to certain sensitive groups including children, adolescents, and low-weight adults. Although the data on plasma caffeine concentrations are mainly derived from reports of severe caffeine toxicities, these observations are decidedly relevant to clinical prediction. A quantitative relationship among plasma caffeine concentrations, pharmacokinetics, and toxicities is yet to be clearly concluded, but well-documented case reports studying caffeine concentration have indicated the following:</p>
    <p>
      <list list-type="order">
        <list-item>
          <p>Plasma caffeine concentrations &lt; 10 mg/L are generally safe, but caffeine concentrations of &gt; 15 mg/L may exert toxicity.[<xref rid="B5" ref-type="bibr">5</xref>]</p>
        </list-item>
        <list-item>
          <p>Fatalities from caffeine intoxication have been reported with plasma caffeine concentrations of &lt; 40 mg/L.[<xref rid="B5" ref-type="bibr">5</xref><xref rid="B13" ref-type="bibr">13</xref>]</p>
        </list-item>
        <list-item>
          <p>Fatal caffeine poisoning cases are usually reported when the concentration is &gt; 80 mg/L.[<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref><xref rid="B17" ref-type="bibr">17</xref>]</p>
        </list-item>
      </list>
    </p>
    <p>The physiological and pathological effects of caffeine ingestion in individuals can be more properly interpreted once the information on toxic caffeine concentration levels from case reports are aptly combined with the concentration-time data simulation obtained through the <italic>caffsim</italic> R package.</p>
    <p>The <italic>caffsim</italic> R package also broadens the perspective on accessibility by creating and utilizing diverse web-based open-science applications such as Shiny app and EDISON Science App. We expect that the EDISON Science App based on the <italic>caffsim</italic> R package will have significant impact on relevant education, and further stimulate the development of open-science applications. This approach makes innovative and state-of-the-art technologies more accessible to both students and the public; also, physicians in training may benefit from it for understanding the pharmacokinetics following one compartment model, and for recognizing caffeine intoxication or caffeine-related syndromes.</p>
    <p>In conclusion, we report that our newly-developed <italic>caffsim</italic> R package and its web-applications enable researchers and clinicians to perform fast, easy-to-use, and versatile simulations of caffeine dosing in various settings (in R console or in desktop and mobile web-browsers). This software will expand our knowledge of the relationship between the plasma caffeine concentration and caffeine intoxication in caffeine-sensitive groups. The <italic>caffsim</italic> R package may help people understand how plasma caffeine concentration changes over time and how long toxic caffeine concentration can last in the plasma of caffeine-sensitive groups. It may also help clinical evaluation of the relationship between caffeine intake and toxicities when suspicious acute symptoms occur.</p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgements</title>
    <p>This research was supported by the EDISON (EDucationresearch Integration through Simulation On the Net) Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: 016M3C1A6936614). We thank Dr. Joon Seo Lim from the Scientific Publications Team at Asan Medical Center for his editorial assistance in preparing this manuscript.</p>
  </ack>
  <fn-group>
    <fn fn-type="other">
      <p><bold>Reviewer:</bold> This article was reviewed by peer experts who are not TCP editors.</p>
    </fn>
    <fn fn-type="COI-statement">
      <p><bold>Conflicts of interests:</bold> -Authors: No potential conflicts of interest relevant to this article were reported.</p>
      <p>-Reviewers: Nothing to declare</p>
      <p>-Editors: Nothing to declare</p>
    </fn>
  </fn-group>
  <ref-list>
    <ref id="B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <collab>EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)</collab>
        <article-title>Scientific Opinion on the safety of caffeine: Safety of caffeine</article-title>
        <source>EFSA J</source>
        <year>2015</year>
        <volume>13</volume>
        <fpage>4102</fpage>
        <pub-id pub-id-type="doi">10.2903/j.efsa.2015.4102</pub-id>
      </element-citation>
    </ref>
    <ref id="B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reissig</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Strain</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>RR</given-names>
          </name>
        </person-group>
        <article-title>Caffeinated energy drinks--A growing problem</article-title>
        <source>Drug Alcohol Depend</source>
        <year>2009</year>
        <volume>99</volume>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2008.08.001</pub-id>
        <pub-id pub-id-type="pmid">18809264</pub-id>
      </element-citation>
    </ref>
    <ref id="B3">
      <label>3</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Pray</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <source>Caffeine in food and dietary supplements: examining safety: workshop summary</source>
        <publisher-loc>Washington D.C</publisher-loc>
        <publisher-name>The National Academies Press</publisher-name>
        <year>2014</year>
      </element-citation>
    </ref>
    <ref id="B4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seifert</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Schaechter</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Hershorin</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Lipshultz</surname>
            <given-names>SE</given-names>
          </name>
        </person-group>
        <article-title>Health Effects of Energy Drinks on Children, Adolescents, and Young Adults</article-title>
        <source>Pediatrics</source>
        <year>2011</year>
        <volume>127</volume>
        <fpage>511</fpage>
        <lpage>528</lpage>
        <pub-id pub-id-type="pmid">21321035</pub-id>
      </element-citation>
    </ref>
    <ref id="B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Banerjee</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ali</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fowler</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Fatal Caffeine Intoxication: A Series of Eight Cases from 1999 to 2009</article-title>
        <source>J Forensic Sci</source>
        <year>2014</year>
        <volume>59</volume>
        <fpage>865</fpage>
        <lpage>868</lpage>
        <pub-id pub-id-type="pmid">24502704</pub-id>
      </element-citation>
    </ref>
    <ref id="B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trabulo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Marques</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pedroso</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Caffeinated energy drink intoxication</article-title>
        <source>BMJ Case Rep</source>
        <year>2011</year>
        <volume>2011</volume>
        <fpage>pii:bcr0920103322</fpage>
        <pub-id pub-id-type="doi">10.1136/bcr.09.2010.3322</pub-id>
      </element-citation>
    </ref>
    <ref id="B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jun</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Baik</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Associations of Caffeinated Beverage Consumption and Screen Time with Excessive Daytime Sleepiness in Korean High School Students</article-title>
        <source>Clin Nutr Res</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>55</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="pmid">28168182</pub-id>
      </element-citation>
    </ref>
    <ref id="B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Temple</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Ziegler</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Graczyk</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Crandall</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Effects of acute and chronic caffeine on risk-taking behavior in children and adolescents</article-title>
        <source>J Psychopharmacol</source>
        <year>2017</year>
        <volume>31</volume>
        <fpage>561</fpage>
        <lpage>568</lpage>
        <pub-id pub-id-type="doi">10.1177/0269881117691568</pub-id>
        <pub-id pub-id-type="pmid">28198658</pub-id>
      </element-citation>
    </ref>
    <ref id="B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Perera</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>McLachlan</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics</article-title>
        <source>J Pharm Pharmacol</source>
        <year>2011</year>
        <volume>63</volume>
        <fpage>1161</fpage>
        <lpage>1168</lpage>
        <pub-id pub-id-type="doi">10.1111/j.2042-7158.2011.01326.x</pub-id>
        <pub-id pub-id-type="pmid">21827488</pub-id>
      </element-citation>
    </ref>
    <ref id="B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Perera</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Forrest</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Landersdorfer</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ait-Oudhia</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity</article-title>
        <source>Drug Metab Dispos</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>1957</fpage>
        <lpage>1966</lpage>
        <pub-id pub-id-type="doi">10.1124/dmd.113.053074</pub-id>
        <pub-id pub-id-type="pmid">23996078</pub-id>
      </element-citation>
    </ref>
    <ref id="B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Perera</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>McLachlan</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Bae</surname>
            <given-names>KS</given-names>
          </name>
        </person-group>
        <article-title>Prediction of plasma caffeine concentrations in young adolescents following ingestion of caffeinated energy drinks: a Monte Carlo simulation</article-title>
        <source>Eur J Pediatr</source>
        <year>2015</year>
        <volume>174</volume>
        <fpage>1671</fpage>
        <lpage>1678</lpage>
        <pub-id pub-id-type="doi">10.1007/s00431-015-2581-x</pub-id>
        <pub-id pub-id-type="pmid">26113286</pub-id>
      </element-citation>
    </ref>
    <ref id="B12">
      <label>12</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Wickham</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>ggplot2: Elegant Graphics for Data Analysis</source>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Springer-Verlag</publisher-name>
        <year>2016</year>
      </element-citation>
    </ref>
    <ref id="B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cannon</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Cooke</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>JS</given-names>
          </name>
        </person-group>
        <article-title>Caffeine-induced cardiac arrhythmi a: an unrecognised danger of healthfood products</article-title>
        <source>Med J Aust</source>
        <year>2001</year>
        <volume>174</volume>
        <fpage>520</fpage>
        <lpage>521</lpage>
        <pub-id pub-id-type="pmid">11419773</pub-id>
      </element-citation>
    </ref>
    <ref id="B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Holmgren</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nordén-Pettersson</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ahlner</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Caffeine fatalities--four case reports</article-title>
        <source>Forensic Sci Int</source>
        <year>2004</year>
        <volume>139</volume>
        <fpage>71</fpage>
        <lpage>73</lpage>
        <pub-id pub-id-type="pmid">14687776</pub-id>
      </element-citation>
    </ref>
    <ref id="B15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kerrigan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lindsey</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Fatal caffeine overdose: two case reports</article-title>
        <source>Forensic Sci Int</source>
        <year>2005</year>
        <volume>153</volume>
        <fpage>67</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="pmid">15935584</pub-id>
      </element-citation>
    </ref>
    <ref id="B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thelander</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jönsson</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Personne</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Forsberg</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Lundqvist</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Ahlner</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Caffeine fatalities--Do sales restrictions prevent intentional intoxications?</article-title>
        <source>Clin Toxicol (Phila)</source>
        <year>2010</year>
        <volume>48</volume>
        <fpage>354</fpage>
        <lpage>358</lpage>
        <pub-id pub-id-type="doi">10.3109/15563650903586752</pub-id>
        <pub-id pub-id-type="pmid">20170393</pub-id>
      </element-citation>
    </ref>
    <ref id="B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Wijkerslooth</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Koch</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Malingré</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Smits</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bartelink</surname>
            <given-names>AKM</given-names>
          </name>
        </person-group>
        <article-title>Lifethreatening hypokalaemia and lactate accumulation after autointoxication with Stacker 2®, a “powerful slimming agent</article-title>
        <source>” Br J Clin Pharmacol</source>
        <year>2008</year>
        <volume>66</volume>
        <fpage>728</fpage>
        <lpage>731</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1365-2125.2008.03279.x</pub-id>
        <pub-id pub-id-type="pmid">18823307</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="S1">
      <caption>
        <title>Supplementary Table 1</title>
        <p>A descriptive summary on the duration (hour) of plasma caffeine concentration over certain levels (40 mg/L or 80 mg/L) previously known to cause serious toxicity. Values were generated by caffOverdose function for 500 subjects per each body weight group. (Abbreviations: SD, standard deviation)</p>
      </caption>
      <media mimetype="application" mime-subtype="pdf" xlink:href="tcp-25-141-s001.pdf" orientation="portrait" id="d35e1069" position="anchor"/>
    </supplementary-material>
  </sec>
</back>
<floats-group>
  <fig id="F1" orientation="portrait" position="float">
    <label>Figure 1</label>
    <caption>
      <title>Development workflow of the <italic>caffsim</italic> R package. Items on the left side can be executed in web browsers and the others are R functions that can be run on the R console. The shiny web-application or <inline-formula><inline-graphic xlink:href="tcp-25-141-i011.jpg"/></inline-formula> function enables users to interactively perform a simulation (Abbreviations: Web-app., web-application.).</title>
    </caption>
    <graphic xlink:href="tcp-25-141-g001"/>
  </fig>
  <fig id="F2" orientation="portrait" position="float">
    <label>Figure 2</label>
    <caption>
      <title>Examples of the <italic>caffsim</italic> R package functions. A) examples by <inline-formula><inline-graphic xlink:href="tcp-25-141-i005.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="tcp-25-141-i006.jpg"/></inline-formula>, B) examples by <inline-formula><inline-graphic xlink:href="tcp-25-141-i007.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="tcp-25-141-i008.jpg"/></inline-formula>, C) examples by <inline-formula><inline-graphic xlink:href="tcp-25-141-i009.jpg"/></inline-formula>, and D) examples by <inline-formula><inline-graphic xlink:href="tcp-25-141-i012.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="tcp-25-141-i013.jpg"/></inline-formula></title>
    </caption>
    <graphic xlink:href="tcp-25-141-g002"/>
  </fig>
  <fig id="F3" orientation="portrait" position="float">
    <label>Figure 3</label>
    <caption>
      <title>Plasma concentration-time profiles derived from 5 times multiple dosing simulations with an interval of 8, 4, 2, and 1 hr. Values were generated by <inline-formula><inline-graphic xlink:href="tcp-25-141-i006.jpg"/></inline-formula> function for 500 subjects per each body weight group. Line plots show the arithmetic mean and shades denote the range of standard errors.</title>
    </caption>
    <graphic xlink:href="tcp-25-141-g003"/>
  </fig>
  <fig id="F4" orientation="portrait" position="float">
    <label>Figure 4</label>
    <caption>
      <title>Shiny web-application using the <italic>caffsim</italic> R package. A) a scatter plot of C<sub>max</sub> according to body weight, B) a scatter plot of AUC<sub>inf</sub> according to body weight, C) a concentration-time plot of single dose, and D) concentration-time plots and box-whisker plot of C<sub>max</sub> opened in mobile web-browsers (Abbreviation: C<sub>max</sub>, Maximal plasma concentration; AUC<sub>inf</sub>; area under the curve infinity).</title>
    </caption>
    <graphic xlink:href="tcp-25-141-g004"/>
  </fig>
  <fig id="F5" orientation="portrait" position="float">
    <label>Figure 5</label>
    <caption>
      <title>EDISON Science App web-application using the caffsim R package. A) An input-deck editor, and B) HTML report containing various information regarding simulation runs.</title>
    </caption>
    <graphic xlink:href="tcp-25-141-g005"/>
  </fig>
  <table-wrap id="T1" orientation="portrait" position="float">
    <label>Table 1</label>
    <caption>
      <title>Explanation on the functions in the <italic>caffsim</italic> R package</title>
    </caption>
    <alternatives>
      <graphic xlink:href="tcp-25-141-i001"/>
      <table frame="hsides" rules="rows">
        <col width="10%" span="1"/>
        <col width="20%" span="1"/>
        <col width="70%" span="1"/>
        <thead>
          <tr>
            <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(96,153,210)">Class</th>
            <th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(96,153,210)">Functions</th>
            <th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(96,153,210)">Description</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="middle" align="center" rowspan="6" colspan="1">Single dose</td>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffConcTime</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Create a concentration-time dataset of single oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffConcTime(Weight = 20, Dose = 200, N = 20)</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffPkparam</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Create a dataset of pharmacokinetic parameters of single oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffPkparam(Weight = 20, Dose = 200, N = 20)</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffPlot</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Plot plasma concentration-time curves of single oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffPlot(caffConcTime(Weight = 20, Dose = 200, N = 20))</td>
          </tr>
          <tr>
            <td valign="middle" align="center" rowspan="6" colspan="1" style="background-color:rgb(233,243,251)">Mulitple doses</td>
            <td valign="middle" align="left" rowspan="2" colspan="1" style="background-color:rgb(233,243,251)">caffConcTimeMulti</td>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Create a concentration-time dataset of multiple oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Usage in R: caffConcTimeMulti(Weight = 20, Dose = 200, N = 20, Tau = 8, Repeat = 4)</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1" style="background-color:rgb(233,243,251)">caffPkparamMulti</td>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Create a dataset of pharmacokinetic parameters of multiple oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Usage in R: caffPkparamMulti(Weight = 20, Dose = 200, N = 20, Tau = 8)</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1" style="background-color:rgb(233,243,251)">caffPlotMulti</td>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Plot plasma concentration-time curves of multiple oral dosing of caffeine.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(233,243,251)">Usage in R: caffPlotMulti(caffConcTimeMulti(Weight = 20, Dose = 200, N = 20, Tau = 8, Repeat = 4))</td>
          </tr>
          <tr>
            <td valign="middle" align="center" rowspan="8" colspan="1">Others</td>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffDescstat</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Calculate descriptive statistics of simulated pharmacokinetic parameters.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffDescstat(caffPkparam(20,500))</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffOverdose</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Calculate a duration of toxic concentration over specified levels (40 mg/L or 80 mg/L).</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffOverdose(caffConcTime(Weight = 20, Dose = 200, N = 20))</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1">caffShiny</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Run Shiny app to interactively simulate single and multiple dosing for plasma caffeine concentration.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: caffShiny()</td>
          </tr>
          <tr>
            <td valign="middle" align="left" rowspan="2" colspan="1">UnitTable</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Unit data of PK parameters.</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Usage in R: UnitTable</td>
          </tr>
        </tbody>
      </table>
    </alternatives>
  </table-wrap>
</floats-group>
